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Abstract
Introduction: Breast cancer, the most common malignancy in women, still holds many secrets. The causes for
non-hereditary breast cancer are still unknown. To elucidate any role for circulating naturally secreted proteins, a
screen of secreted proteins’ influence of MCF10A cell anchorage independent growth was set up.
Methods: To systematically screen secreted proteins for their capacity to transform mammalian breast epithelial
cells, a soft agar screen of MCF10A cells was performed using a library of ~ 470 secreted proteins. A high
concentration of infecting viral particles was used to obtain multiple infections in individual cells to specifically
study the combined effect of multiple secreted proteins.
Results: Several known breast cancer factors, such as Wnt, FGF and IL were retained, as well as factors that were
previously unknown to have a role in breast cancer, such as paraoxonase 1 and fibroblast growth factor binding
protein 2. Additionally, a combinatory role of Interleukin 6 with other factors in MCF10A anchorage-independent
growth is demonstrated.
Conclusion: The transforming effect of combinations of IL6 with other secreted proteins allows studying the
transformation of mammary epithelial cells in vitro, and may also have implications in in vivo studies where
secreted proteins are upregulated or overexpressed.
Introduction
Breast cancer is the most common malignancy in
women, accounting for 1/3 of all cancers in women and
the highest cancer-related mortality in women. While
many breast cancer oncogenes have been identified, the
causes for the majority of sporadic breast cancers are
unknown.
Studies with Mouse Mammary tumor Virus (MMTV)
in mice have indicated that enhanced expression of a
number of secreted proteins, such as Wingless-type
MMTV integration site family (Wnt), Fibroblast growth
factor (FGF) and R-spondin (RSPO), are associated with
the development of breast cancer [1-7]. However, when
overexpressed in mammary epithelial cells, these
proteins do not transform cells. Also, mice transgenic
for Wnt or FGF proteins develop breast cancer in a sto-
chastic manner, indicating that a second event is neces-
sary for breast cancer development [1,8]. Taken
together, these findings indicate that while these
secreted factors are important contributing factors, indi-
vidually, they are not sufficient for full transformation of
breast epithelial cells.
It has also been shown that cytokines can have both a
stimulatory or inhibitory effect on breast cancer cells,
depending on their relative concentrations and the pre-
sence of other factors in the microenvironment [9]. This
indicates that the cooperative or antagonistic effects of
multiple secreted factors may be more decisive than the
individual factors in determining cellular behavior.
We have set out to investigate the co-operative action
of secreted proteins in the transformation of breast
epithelial cells. We have constructed an expression
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and used it to infect human breast epithelial cells at
high multiplicity of infection (MOI), with the goal to
achieve multiply infected cells, expressing combinations
of secreted factors. These cells were selected by growth
in soft agar, and the infecting cDNA’s were recovered.
Analysis of about 300 colonies revealed that it is indeed
possible to obtain multiple infection of MCF10A cells
through retroviral infection. The cDNA’s recovered
from the selected cells reveal a high recurrence of genes
that have previously been implicated in breast cancer
development, such as Wnt and FGF proteins, while at
the same time revealing high recurrences of genes that
had previously not been directly linked to breast cancer
development, such as FGF-binding proteins and paraox-
onases. Furthermore, the high incidence of multiple
infections in the selected colonies indicate that multiple
factors are needed for successful anchorage-independent
growth of MCF10A cells. We demonstrate that particu-
larly interleukin 6, when combined with other factors,
but not alone, is effectively driving anchorage indepen-
dent growth in MCF10A cells.
Materials and methods
1. Cell lines
MCF10A cells were obtained from American Type
C u l t u r eC o l l e c t i o na n dg r o w ni nD u l b e c c o ’sm o d i f i e d
Eagle’s medium supplemented with 5% horse serum,
20 ng/ml epidermal growth factor, 0.5 μg/ml hydrocorti-
sone, 100 mg/ml cholera toxin, 10 μg/ml insulin and
penicillin/streptomycin. The amphotropic Phoenix
packaging cell line was obtained from the Nolan Labora-
tory, Stanford University and grown in DME medium,
supplemented with 10% Fetal Calf Serum.
2. Cloning of library
A total of 469 cDNA’s were cloned into either pBABE-
puro, or a slightly modified pBABE-puro, pBABE-I, ret-
roviral vectors (see additional file 1: figure S1). pBABE-I
was created by replacing the SV40 promoter in pBABE-
puro with the PGK promoter by PCR from the pSIREN
vector (Clontech). The PGK promoter fragment was
amplified by PCR with primers forward: GAGGGATCC-
GAATTCCACCATGGCTGACAGATCTTAATGAGTC
GACAATTGTACCGGTAGGGGAGGC; and reverse:
AGAGTTCTTGCAGCTCGGTGAC; and cloned into
the BamHI-BsiWI cut pBABE-puro. The primers con-
tain restriction enzyme recognition sites (underlined) for
an altered MCS in pBABE-I. No difference in produc-
tion of viral particles by either vector has been observed.
About half of the clones were cloned in pBABE-puro,
and about half in pBABE-I. Most cDNA’sw e r ec l o n e d
by PCR from the MegaMan Human Transcriptome
Library (Stratagene), or were obtained by RT-PCR from
tissue-specific mRNA (purchased from Clontech).
Others were cloned by PCR from EST clones that were
obtained via RZPD (Germany) or the IMAGE consor-
tium (via ATCC). Before the ATG codon of the clones,
a KOZAK sequence was inserted. All clones were veri-
fied by full-length sequencing.
3. Soft agar screen
The library was subdivided in 13 random groups of
about 37 clones, and transfected in the AMPHO cell
line using Effectene (Qiagen). Forty-eight hours later,
virus-containing supernatants from all groups were
combined (about 790 ml was recovered), filtered
(0.45 μM filter; Millipore) and concentrated by spinning
in SA600 rotor at 15000 RPM for 2 hours in a Sorvall
centrifuge. The viral pellets were resuspended in a final
volume of 90 ml. This medium was supplemented with
5 μg/ml polybrene (Sigma-Aldrich), and evenly distribu-
ted over 6 15-cm dishes of MCF10A cells that had been
seeded at 3 × 10
6 cell/dish 24 hours before.
After 24 hours, the infected MCF10A cells were tryp-
sinized, counted, and seeded in puromycin (1 μg/ml)
containing soft agar (2 × 10
6 cell/15 cm dish). The
dishes were maintained for four weeks, and 15 ml of
medium with puromycin was added once per week.
Many differently sized colonies could be observed.
A total of 400 larger colonies were picked and plated in
normal puromycin-containing medium and allowed to
grow and expand. About 300 colonies were found to be
viable. Total DNA was purified from 10
6 cells of each
expanded colony using the FlexiGene DNA kit (Qiagen).
Three different PCR reactions were performed with
each genomic DNA samples, one with G3PDH primers
to verify DNA quality, one with a set of pBABE-puro
(Primers: For: ctaagcctccgcctcctcttcttcc; Rev: gcctcc
cctacccggtagaattgtc) and the last with pBABE-I (Primers:
For: ctaagcctccgcctcctcttcttcc; Rev: ggactttccacacctggtt
gctgac) specific primers, respectively. All PCR products
were purified from agarose gels and subjected to direct
sequencing with primer gcctcctcttcttccatccg. Sequencing
results were subjected to BLAST searches on the NCBI
webservice to identify the inserts.
4. Soft agar setups (small scale)
AMPHO cells were transfected using FuGene 6 (Roche)
or Effectene (Qiagen) according to manufacturer recom-
mendations. The obtained viral supernatant was filtered
and used to infect 6-well of MCF10A cells. Three
changes of the viral supernatant was used over a period
48 hours. When combinations of different protein inter-
actions were required, individual retroviral constructs
were transfected, and viral supernatants were combined
at the time of infection. Infected cells underwent
puromycin-selection and were grown for 3-5 days,
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base at 20,000 cells/well in 6-well dishes. Fresh Medium
was added twice per week with the old medium being
removed once during the week. After 4 weeks, colonies
were stained with Thiazolyl Blue Tetrazolium Bromide
for 4 hours at room temperature, destained multiple
times with water, and then analyzed.
Results and Discussion
1. Construction of library
To construct the secretomics library, we selected candi-
date proteins on basis of reported secretion, predicted
secretory domains or signals, or homology to known
secreted proteins. Most of the proteins in our library are
500 or less amino acids in size, so as to allow for effi-
cient infection and expression in a retroviral system. At
the time of the experiments described in this report, our
library contained 467 different proteins. Our library con-
tained both individual proteins, and multiple members
of protein families, such as 16 different Wnt proteins,
22 FGF proteins, 35 interleukins, and 15 kalikreins (see
additional file 2: table S1). The library was constructed
in the selectable retroviral vector pBABE to allow for
wide application.
2. Infection of MCF10A cells
In order to study the combinatory effect of multiple
secreted factors on a single cell, we infected the cells with
a mixture of retroviral particles at a high concentration.
A Flow-chart of the screen process is shown in figure 1.
We subdivided the library in 13 subgroups, which were
used to transfect the amphotropic packaging cell line. To
ensure complete random infection, the retroviral particles
o b t a i n e df r o mt h es u p e r n a t a n to ft h et r a n s f e c t e ds u b -
groups were combined, concentrated by centrifugation,
and applied to the MCF10A cells. The infected cells were
seeded in soft agar, where wild type MCF10A cells are
unable to grow, and selected for 4 weeks. About 400 of
the formed colonies were extracted from the soft agar
and grown in MCF10A medium with puromycin under
normal growth conditions.
About 300 of these colonies grew successfully and
were expanded, and genomic DNA was extracted. The
incorporated clonal DNAs were amplified from the total
genomic DNA by PCR with retroviral vector-specific
primers, purified from the agarose gel, and then
sequenced. The sequences were scanned for the recog-
nizable vector-specific sequences and as well as sub-
jected to BLAST analysis.
Analysis of the recombinant DNAs that were recov-
ered from the selected soft agar colonies revealed that
both single and multiple infections had occurred. As
shown in figure 2, multiple infections (up to 11 inserts
in one colony) of different DNA insertions were
achieved in this screen. The majority of recovered colo-
nies (about 70%; 206 out of 297 colonies) contained
combinations of 2 to 4 DNA inserts. Only about 10% of
colonies (32 out of 297) contained a single DNA insert,
indicating that the over expression of a single insertion
may be less efficient to promote anchorage independent
growth in MCF10A.
3. Screen analysis
The full list of recovered inserts is listed in the addi-
tional tables. Additional file 3: Table S2 gives a listing of
all inserts recovered from the colonies while Additional
file 4: Table S3 gives the same listing classified by the
Transfection of packaging cell line
harvest virus - concentrate
infection
harvest cells -  seed soft agar
pick colonies
expand colonies - extract DNA
PCR - sequence - analysis
Library, subdivided in 13 groups
24 hours
24 hours
4 weeks
1-5 weeks
Figure 1 Flow-chart of screen procedures.
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actual inserts identified from each colony picked.
The top inserts are listed, by recurrence of individual
insertions with the highest frequency in Table 1 and by
recurrence of members of a protein family in Table 2.
Several of the highly recurring proteins in our screen
were previously shown to be involved in breast cancer
development.
Interleukins as a family of proteins are widely repre-
sented in this screen. With 97 inserts, spread over 83
colonies, interleukins are present in just under one third
of the colonies. Interleukin 6 (16 inserts), IL21 (12
inserts), IL22 (11 inserts) and IL27 (9 inserts) are the
most recurring interleukins. Serum levels of IL6 have
been found to be elevated in breast cancer patients [10],
and pretreatment IL6 serum levels can predict treatment
outcome and prognosis [11,12].
Furthermore, autocrine IL-6 expression causes multi-
drug resistance in breast cancer cells [13], and IL-6
enhances mammosphere formation and self-renewal [14].
IL21-expressing breast adenocarcinoma cells did not have
growth characteristics different from parental cells, but
could not efficiently form tumors in mice [15], and pro-
tected the mice from subsequent challenges with the par-
ental adenocarcinoma cells, indicating an immunological
response. IL22 has been reported to inhibit proliferation of
breast adenocarcinoma cells, both in vivo and in vitro [16].
IL27 has not been implicated in breast cancer, but has a
potential role in other tumor types [17,18].
IL6 inhibition and IL21, among other interleukins, are
currently being studied in clinical trials for different
tumor types [19,20].
Wnt3, with 31 recurrences in this screen, and its close
homologue Wnt3a were also highly recurrent in a
mouse study on breast cancer development by MMTV
infection [7]. Remarkable is that Wnt1, which was the
first Wnt gene to be implicated in breast cancer [3] was
only recovered in 1 colony in our screen.
Our study also reveals high recurrence of FGF14,
FGF10 and FGF1. MMTV studies in mice have
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Figure 2 Distribution of viral infections. The number of colonies from which the same number of cDNA inserts were recovered shows
multiple infection took place in the screen.
Table 1 List of DNA inserts from screen colonies
total inserts % of all inserts protein Protein family Description Role in Breast cancer
68 6.9% WFDC13 WFDC WAP Four-Disulfide Core Domain 13 no
36 3.6% PON1 PON Paraoxonase 1 no
31 3.1% Wnt3 Wnt Wingless-type MMTV Integration Site Family, Member 3 [7]
18 1.8% FGFBP2 FGFBP Fibroblast Growth Factor Binding Protein 2 no
15 1.5% IL6 Interleukin Interleukin 6 (Interferon, Beta 2) [10]
15 1.5% FGF14 FGF Fibroblast Growth Factor 14 no
14 1.4% SAA1 SAA Serum Amyloid A1 [24]
14 1.4% PTHLH PTHLH Parathyroid Hormone-Like Hormone [23]
13 1.3% FGF10 FGF Fibroblast Growth Factor 10 [6]
12 1.2% LYNX1 Ly-6 Ly6/Neurotoxin 1 No
12 1.2% IL21 Interleukin Interleukin 21 Refs in [38]
11 1.1% IL22 Interleukin Interleukin 22 [16]
10 1.0% WFDC14 WFDC Peptidase Inhibitor 3, Skin-Derived (SKALP) no
10 1.0% SUMF1 SUMF Sulfatase Modifying Factor 1 no
10 1.0% FGF1 FGF Fibroblast Growth Factor 1 (acidic) [22]
The most recurrent DNA inserts recovered from screen colonies are listed, with indication of the protein family they belong to, and publications linking the
proteins to breast cancer development.
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[6,21]) in mouse breast cancer development. Other
FGF’s have not been directly implicated in breast cancer,
but the role of FGF receptor 2 (FGFR2) indirectly impli-
cates FGF1, FGF2, FGF3, FGF4, FGF6, FGF7, FGF9,
FGF10, FGF16, FGF20 and FGF22 [22]. While several
FGF proteins had been previously implicated in breast
cancer development, we found FGF14, previously not
implicated in breast cancer development, to be the high-
est recurring FGF in our screen. Equally remarkable is
that, while FGF3, FGF4 and FGF8 had been implicated
before, they did not feature high in our screen, with
FGF14, FGF10 and FGF1 being high up in our screen.
Parathyroid hormone like hormone (PTHLH, also
Parathyroid hormone related protein, PTHrP), recurring
14 times in our screen, is elevated in 60 to 90% of breast
cancers, and is implicated in breast cancer metastasis to
bone [23]. Serum amyloid proteins (SAA1/2) are repre-
sented by SAA1 in our screen, and SAA1 present in 14
of our colonies. Serum levels of this acute-phase protein
are increased in cancer patients, including breast cancer
patients [24], with an indication that higher SAA levels
in breast cancer patients represent more metastasis and
poorer prognosis.
WAP Four-Disulfide Core Domain (WFDC) proteins
have not been thoroughly studied. Many WFDC coding
genes are clustered on 20q12-13.1, a region that is
amplified in several cancers, including breast cancer
[25,26]. Four WFDC proteins have been indicated as
candidate cancer biomarkers (WFDC14 (elafin), WFDC4
(SLPI), WFDC2 and WFDC1) [27]. WFDC13, the most
prevalent insert in our screen has not been studied
before. Other prevalent WFDC proteins in our screen
are WFDC14, WFDC4 and WFDC11.
The second-most prevalent protein in our screen is
paraoxonase1 (PON1), a High density lipoprotein-asso-
ciated enzyme, naturally secreted by the liver, that
shows protective properties in cardiovascular disease
and organophosphate poisoning [28]. Few reports sug-
gest a possible link between PON1 and breast cancer:
the L55M single nucleotide polymorphism in PON1 has
been associated with increased risk of breast cancer in
Table 2 List of protein families recovered from screen colonies
total inserts Total colonies % of all colonies Protein family
97 83 27.9% Interleukin Interleukin
97 88 29.5% WFDC WAP Four-Disulfide Core Domain
78 72 24.2% FGF Fibroblast Growth Factor
54 54 18.1% Wnt Wingless-type MMTV Integration Site Family
40 39 13.1% PON Paraoxonase
35 34 11.4% KLK Kalikrein
33 28 9.4% TGFB Transforming Growth Factor
21 19 6.4% CXCL CXC Chemokine Ligand
21 21 7.0% DEF Defensin
21 21 7.0% FGFBP Fibroblast Growth Factor Binding Protein
26 26 8.7% TIMP Tissue Inhibitor of Metalloproteinase
19 19 6.4% CCL CC Chemokine Ligand
19 19 6.4% IGFBP Insulin-like Growth Factor Binding Protein
18 18 6.0% RSPO R-Spondin
16 15 5.0% DKK Dickkopf
15 15 5.0% SAA Serum Amyloid
14 14 4.7% PTHLH Parathyroid Hormone-Like Hormone
14 14 4.7% SFTP Surfactant Protein
14 14 4.7% WISP Connective Tissue Growth Factor
13 13 4.4% APO Apolipoprotein
13 13 4.4% Ly-6 Ly6/uPAR
13 13 4.4% PGLYRP Peptidoglycan Recognition Protein
12 12 4.0% MASP MBL-associated Serine Protease
10 10 3.4% FAM3 Family with Sequence Similarity 3
10 10 3.4% IFN Interferon
10 10 3.4% SPARC Secreted Protein Acidic and Rich in Cysteine
10 10 3.4% SUMF Sulfatase Modifying Factor
The DNA recovered from the screen colonies was grouped in protein families, and the most prevalent protein families are listed here. As multiple protein family
members may co-occur in a single colony, the number of colonies may be less than the number of inserts where the protein family is represented. Proteins that
have no family members in this screen are listed as individual proteins.
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(Q192R) had no effect in one study [29], but showed a
decreased breast cancer risk in another study [30]. The
PON1 clone in our library has L on pos 55 and Q on
pos 192. PON1 expression is reported to be upregu-
lated by estrogen receptor alpha (ERa) [31], and inde-
pendently by resveratrol, a substance believed to be
the main active ingredient in the cardio-protective
effects of red wine, and which is also activating the ER
receptor [31].
Fibroblast growth factor binding protein 2 or FGFBP2
(also termed Ksp37, killer specific secretory protein of
37 kDa) is secreted by Th1-type CD4+ lymphocytes
with cytotoxic potential [32]. Increased FGFBP2 expres-
sion has been correlated with longer survival in glioblas-
toma [33]. Other links to cancer have not been
published. Family member FGF-BP1 however has been
implicated in breast cancer.
Lynx1 is a member of the lymphocyte Antigen 6 (Ly-6)
superfamily of cysteine-rich proteins that are mostly GPI
anchored to the cell membrane. Only 3 proteins in the
family are secreted, and Lynx-1 (or SLURP-2) has been
described to be upregulated in Psoriasis vulgaris [34],
while another non-secreted family member, Ly-6K, was
identified as a biomarker for breast cancer [35].
The sulfatase modifying factor 1 (SUMF1) that is pre-
sent in 10 of our colonies has previously never been
described as involved in any types of tumors. It is
essential for the post-translational modification of sulfa-
tases, and deficiency results in an autosomal recessive
disorder [36].
4. Reconstructive analysis
As had been previously reported for a number of the
proteins tested in this screen, the infection of MCF10A
cells with single viral vectors led to no or very weak
growth in soft agar (data not shown).
In performing this screen, MCF10A cells were purpo-
sefully infected with concentrated viral particles, in
order to achieve multiple infection of the cells. In this
way, the importance of the combination of different fac-
tors on the growth of MCF10A cells in soft agar could
be assessed. A schema of some combinations of factors
is provided in figure 3, where the more prevalent recur-
ring combinations are indicated in red. While we cre-
ated viral particles by transfecting 13 distinct subgroups,
the pooling and concentration of the viral particles ren-
dered a random distribution in infection. This was
observed by the fact that the factors found in the soft
agar colonies did not return with a clear correlation to
the distribution in the 13 subgroups.
It had been previously observed in MMTV-mouse
studies that FGF and Wnt genes may co-operate in
breast cancer development. Mice that are transgenic for
a Wnt protein predominantly overexpressed FGF genes
in MMTV-induced breast tumors, and vice versa
[1,2,37]. A total of 14 of the colonies in our screen con-
tained combinations of Wnt and FGF family members,
suggesting that FGF-Wnt co-operation in transformation
of human mammalian cells may also occur. However,
when any of the top 5 FGFs were co-infected with Wnt
3 or Wnt8a in MCF10A cells, we did not observe strong
growth of these cells in soft agar (figure 4A), indicating
that on a cellular level, the FGF-Wnt combination is not
sufficient to drive efficient transformation. Wnt9a could
not be tested in this assay, as infection of Wnt9a
reduced the survival of the MCF10A cells, not allowing
the soft agar assay.
Six of the colonies in the present screen contained a
combination of two FGF proteins. However, co-infection
of two FGF proteins into MCF10A cells did not lead to
significant growth in soft agar (figure 4B).
In 13 colonies, multiple interleukin family members
were observed to be present. Infection of combinations
of interleukins in MCF10A cells, lead to the observation
that Interleukin 6 (IL6), when combined with IL9 or
IL21 efficiently drives soft agar growth in MCF10A cells.
Other combinations, such as IL6 with IL22, IL21 with
IL27; or IL9 with IL27, did result in some soft agar
growth, but to a much lesser extent than IL6-containing
combinations (figure 5A).
Another prevalent combination in the screen was
interleukins and FGF proteins (19 colonies). When these
combinations were tested in MCF10A cells, IL6 in com-
bination with FGF1, FGF10 or FGF14, proved to effi-
ciently drive these cells to grow in soft agar, while the
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Figure 3 Analysis of combinations recovered from the screen.
The number of times proteins from the indicated protein families
occur in a single colony. Yellow boxes indicate numbers from 2-4,
orange indicate 5-7, and red indicate more than 7 colonies
containing the indicated combination.
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Page 6 of 12FGF alone, or IL6 alone, could not do so (Figure 5B).
This is however in contrast to Wnt proteins, which do
not show any increased growth in soft agar after co-
infection with IL6 (Figure 5C).
Seeing how interleukins and fibroblast growth factors
both show increased growth in soft agar after co-infection
with IL6, other prevalent proteins from our screen were
tested in combination with IL6, and grown in soft agar. As
shown in figure 6, MCF10A cells infected with combina-
tions of IL6 with many of the top inserts of the screen
could grow in soft agar to some extent. While soft agar
growth of the tested combinations was not really robust, it
was significantly stronger than soft agar growth induced
by the individual proteins.
Wnt8a + 
FGF4
Wnt8a + 
FGF4
Wnt8a + 
FGF23
Wnt8a + 
FGF23
Wnt8a + 
FGF14
Wnt8a + 
FGF14
Wnt3 + 
FGF23
Wnt3 + 
FGF23
Wnt8a + 
FGF10
Wnt8a + 
FGF10
Wnt8a + 
FGF1
Wnt8a + 
FGF1
Wnt8a Wnt8a Wnt3 Wnt3
Wnt3 + 
FGF14
Wnt3 + 
FGF14
Wnt3 + 
FGF0
Wnt3 + 
FGF0
Wnt3 + 
FGF4
Wnt3 + 
FGF4
Wnt3 + 
FGF1
Wnt3 + 
FGF1
FGF4 FGF4
FGF23 FGF23
FGF14 FGF14
K-Ras G12V K-Ras G12V
FGF10 FGF10
FGF1 FGF1
E.V. E.V. A E.V. E.V. K-Ras G12V K-Ras G12V
FGF14 FGF14
FGF1 FGF1
FGF1 + 
FGF14
FGF1 + 
FGF14
FGF10 FGF10
FGF1 + 
FGF10
FGF1 + 
FGF10
FGF10 + 
FGF14
FGF10 + 
FGF14
B
Figure 4 Combinations of FGF, or FGF with Wnt do not induce growth in soft agar. MCF10A cells were infected with the indicated
cDNA’s, and seeded in soft agar conditions. After four weeks of growth, wells were stained with MTT and destained with water. One of three
replicates is shown.
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With this screen, the combinatory effect of secreted fac-
tors on breast cancer development was assessed,
through their action on anchorage-independent growth
of MCF10A cells. While screens looking for individual
proteins involved in tumor development have been
described many times, this is the first screen looking for
combinatory action of proteins. In the living organism,
it is understood that every cell and tissue is constantly
surrounded by a mix of hormones, secreted factors, as
well as factors in the extracellular matrix. A different
composition of this environment can seriously affect the
E.V. E.V. K-Ras G12V K-Ras G12V
IL6 IL6
IL9 IL9
IL27 IL27
IL21 IL21
IL6 + IL21 IL6 + IL21
IL6 + IL9 IL6 + IL9
IL27 + IL9 IL27 + IL9
IL21 + IL27 IL21 + IL27
IL22 IL6 + IL22
A E.V. E.V. K-Ras G12V K-Ras G12V
IL6 IL6
FGF14 + IL6 FGF14 + IL6
FGF10 + IL6 FGF10 + IL6
FGF1 + IL6 FGF1 + IL6
FGF14 FGF14
FGF1 FGF1
FGF10 FGF10
B
E.V. E.V. K-Ras G12V K-Ras G12V
Wnt3 + IL6 Wnt3 + IL6 Wnt3 Wnt3
IL6 IL6
C
Figure 5 Combinations of Interleukins, or interleukin 6 with FGF induce soft agar growth, while IL6 combined with Wnt does not.
MCF10A cells were infected with the indicated cDNA’s, and seeded in soft agar conditions. After four weeks of growth, wells were stained with
MTT and destained with water. One of three replicates is shown.
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the growth and other characteristics of the cells and
tissue.
One of the benefits of this screen is also that it
screened a large number of proteins that were
categorized in familial clusters (e.g. 22 FGF proteins, 16
Wnt proteins, 35 interleukins). This brought more
obscure protein family members in the spotlight than
conventional research had done so far. Often, the more
recently discovered members of protein families remain
PON1 + IL6
TIMP1
E.V. E.V. K-Ras G12V K-Ras G12V WFDC13 WFDC13 + IL6
PON1
TIMP1 + IL6 E.V.
E.V.
E.V.
K Ras G12V
K Ras G12V
K Ras G12V FGFBP2
WFDC14 E.V. K-RAS G12V WFDC14 + IL6
FGFBP2 + IL6
E.V.
E.V. K-RAS G12V
K-RAS G12V
GDF8 + IL6
NODAL + IL6 NODAL
GDF8
KR a sG 1 2 V
Figure 6 Combinations of IL6 with other proteins results in soft agar growth. MCF10A cells were infected with the indicated cDNA’s, and
seeded in soft agar conditions. After four weeks of growth, wells were stained with MTT and destained with water. One of three replicates is
shown.
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often extrapolated from more researched close family
members.
Alternative screens have utilized expression profiles or
2D-gel electrophoresis combined with sequencing to
directly identify proteins expressed or secreted in speci-
fic tissues. While these assays are definitely valid, they
usually will have problems picking up subtle differences
in expression, or proteins that are secreted at low levels.
Furthermore, the validation of these proteins in in vitro
assays may be hampered by the fact that alone, these
proteins may not induce the phenotype they were
screened for, and specific combinations of factors may
not be recognized.
Proteins that had previously been implicated in breast
cancer development, such as fibroblast growth factors
and wnt proteins, were also highly recurrent in the pre-
sent screen. As had been shown before in mouse stu-
dies, individual MMTV insertions appear to be sufficient
for tumor formation in mouse, but in MCF10A cells,
overexpression of the corresponding single protein can-
not induce strong soft agar growth. While studies with
MMTV in mouse indicated a potential combinatory role
for Wnt and FGF [1,2,37] in breast cancer development,
in the human cell line MCF10A, these two factors did
not induce anchorage-independent growth. This appar-
ent discrepancy could be due to the difference in spe-
cies, but also to the in vivo nature of the mouse
experiments, and the in vitro nature of the present
screen. In mouse, natural secreted proteins present in
the tissue could further influence the cancer develop-
ment, while in the controlled environment of tissue cul-
ture, this is not the case.
A surprising combination of proteins that did induce
anchorage independent growth in MCF10A cells were
interleukins, which, when combined with other factors,
often greatly enhanced soft agar growth. Interleukin 6,
when co-expressed with other proteins prevalent in our
screen, induced growth in soft agar, albeit to varying
degrees, depending on the co-expressed protein. The
most growth-inducing combination we detected were
combinations between interleukins, such as IL6-IL21, or
IL6-IL9. The combination between IL6 and FGF1,
FGF10 or FGF14 also resulted in strong growth of
MCF10A in soft agar. Only a few of the tested combina-
tions with IL6 did not significantly induce soft agar
growth of MCF10A. Among these was Wnt3, which,
when expressed alone, already has a limited soft agar
growth-inducing potential.
We have discussed above what combinations of
highly expressing proteins promote anchorage inde-
pendent growth in soft agar. However, some of the
combinations found in the initial screen did not induce
colony formation in the validation studies. For this we
should consider other factors such as over-expression
(both relative and absolute) and the influence of pro-
teins secreted by surrounding cells during the screen-
ing process.
The findings in the present study can have important
implications, even for seemingly unrelated research
fields. For example, paraoxonase 1, overexpression of
which had hitherto not been associated with breast can-
cer, has been mainly studied for its beneficial effect in
organophosphate poisoning. Using this protein in pre-
vention of poisoning (e.g. in chemical warfare) may have
serious implications, such as breast tumor development,
should at the time of high PON1 levels, IL6 levels also
be raised.
The results of this screen show that it is possible to
find combinatory effects of proteins in a cell-based
screen, and that such combinatory effects can be very
different from the individual proteins’ effects. Further
analysis will have to be done to examine which signal
transduction pathways are involved in the stimulatory
effect IL6 has with other proteins in anchorage-indepen-
dent growth of mammary epithelial cells.
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